(Q50851322)

English

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. (English)

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

H L Bonkovsky

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

J M Woolley

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

29

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

264-270

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C in asymptomatic blood donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Health assessment for chronic HCV infection: results of quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of hepatitis C virus RNA after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative measurement sensitivity of short and longer health status instruments.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290124

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510290124

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9862876

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50851322&oldid=1590453675"